Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment-MedSci.cn

Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment

Tervonen, T; Prawitz, T; Chua, GN; Hyacinthe, J; Pinto, CA

Tervonen, T (通讯作者)，Evidera, 201 Talgarth Rd, London W6 8BJ, England.;Tervonen, T (通讯作者)，Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022; 144 (): 1

Abstract

Objectives: To assess the effect of patient preferences on the net clinical benefit (NCB) of an antiplatelet therapy for the secondary prevention of c......

Full Text Link